Global Market for Genotyping
Global Genotyping Strategic Business Report 2023: Expanding Applications of DNA Sequencing Offer Significant Opportunities
May 16, 2023 04:08 ET | Research and Markets
Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Genotyping - Global Strategic Business Report" report has been added to's offering.The global market for Genotyping estimated at...
Global Pharmacogenomics Market
Global Pharmacogenomics Market Report 2022: A $10.5 Billion Market by 2030 - Key Players are Extensively Involved in Seeking Approvals and Product Launches to Remain Competitive
February 28, 2023 07:53 ET | Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market Growth Analysis by Service, Technology, Application, End-user - Industry Revenue Estimation and Demand Forecast to 2030"...
Genomics In Cancer Care Global Market to Grow by 19.72% Annually Through 2029
November 08, 2022 06:33 ET | Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Genomics In Cancer Care Market Analysis by Product, by Application, by Technology, End user and by Region - Global Forecast to 2029" report has been...
Global Genotyping Market
Global Genotyping Market Report 2022: Rising Demand for Genotypic-Based Diagnostic Testing Bolstering Growth
September 21, 2022 07:23 ET | Research and Markets
Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) -- The "Genotyping Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to's...
Genotyping Market Size Worth $79.4Bn by 2028 at 20.1% CAGR, Colossal Market Share (by F. Hoffmann-La Roche Ltd. & Illumina, Inc.), Lead by Product and Services Segment, Deep Dive Global Analysis by The Insight Partners
June 30, 2022 09:48 ET | The Insight Partners
New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions
October 28, 2021 08:15 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...
Global Genome Sequencing Market Report 2021-2026 Featuring Prominent Players - Illumina, Thermo Fisher Scientific, Oxford Nanopore Technology, Pacific Biosciences, F. Hoffmann-La Roche, & BGI
March 29, 2021 05:23 ET | Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Genome Sequencing Market - Global Outlook and Forecast 2021-2026" report has been added to's offering. The global genome...
Outlook on the Pharmacogenomics Global Market to 2030 - Trend Forecasts and Growth Opportunities
February 10, 2021 07:33 ET | Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology (PCR, Microarray, Sequencing, Electrophoresis, MS),...
National Lipid Association Releases Official Scientific Statement on Genetic Testing in Dyslipidemia
July 10, 2020 12:30 ET | National Lipid Association
JACKSONVILLE, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official scientific statement on the use of genetic testing in the...
Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
September 06, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming 21st...